Closed

AHCM 312 02 IMM(PQQ) - Individualised immunotherapy medicine

Description

Austin Health is pleased to invite you to respond to this PQQ. Austin Health is seeking a supplier who can provide: Manufacture and supply of Autologous anti-CD19 CAR-T cell for therapy in relapsed CD19+ Diffuse large B cell lymphoma, primary mediast...

Categories

  • Disease prevention and control (50%)
  • Healthcare Services (50%)

Specification documents

1 document

See every tender in full

One Premium plan covers every opportunity across Australia and New Zealand.

  • Full details, briefings and documents
  • Buyer and contact details
  • Saved searches with full alerts
  • Track opportunities
  • Your full supplier profile

Premium

A$116.66/mo

Upgrade to Premium

Billed as a single annual payment of A$1,399.95 excl. GST